Zambia Cholera Vaccines Market Poised to Witness High Demand

Zambia Cholera Vaccines Market

The Zambia cholera vaccines market is expected to benefit from the rising cases of cholera infection in the region. Cholera is a potentially life-threatening intestinal disease caused by the Vibrio cholerae bacteria resulting in diarrhea and dehydration. As a preventive measure, oral cholera vaccines are administered to at-risk populations like military personnel deployed to cholera endemic areas and international travelers.

The Global Zambia Cholera Vaccines Market is estimated to be valued at US$ 1.47 Mn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 To 2031.

Cholera outbreaks are becoming recurrent in Zambia due to inadequate sanitation facilities and contamination of drinking water sources. Oral cholera vaccines play a crucial role in controlling the spread of the disease during outbreaks in at-risk communities. The bivalent killed whole-cell oral vaccine is widely utilized for mass vaccination campaigns conducted by humanitarian organizations. There is growing awareness regarding prophylactic cholera vaccination even in non-epidemic settings. This is anticipated to fuel the demand for cholera vaccines in Zambia over the next few years.

Key Takeaways

Key players operating in the Zambia cholera vaccines are Biovac Inc., Valneva SE., EMERGENT, Astellas Pharma Inc, Sanofi, EUBIOLOGICS CO., LTD,Johnson & Johnson Services Inc., Celldex Therapeutics. The rising prevalence of cholera cases due to poor sanitation infrastructure and contaminated water supply in Zambia is expected to drive the demand for cholera vaccines. Furthermore, implementation of mass vaccination programs by international organizations during outbreaks also necessitates the scale-up of vaccine production and distribution channels.

Growing awareness regarding the importance of cholera immunization even in non-epidemic settings to curb the spread of the disease is also boosting the adoption of Zambia Cholera Vaccines Market Growth. With the support of international health agencies, manufacturers are expanding their production capacities and forging strategic partnerships with local public health organizations for sustainable vaccine delivery. This is anticipated to fuel the growth of the Zambia cholera vaccines market over the forecast period.

Market Key Trends

One of the key trends gaining traction in the Zambia cholera vaccines market is the development of improved vaccine formulations. Currently, the globally used vaccines are oral bivalent WC-rBS and inactivated parenteral vaccines. However, manufacturers are focusing on the development of oral multivalent vaccines with enhanced immunogenicity to provide longer lasting protection against newer cholera strains. Another notable trend is the integration of cholera immunization with other routine Expanded Programs on Immunization (EPI) to facilitate year-round low-cost vaccination access to the population. This approach ensures high vaccination coverage without depending on outbreak responses alone.

Porter’s Analysis

Threat of new entrants: Vaccine production requires huge investments and regulatory approvals, limiting new competitors.

Bargaining power of buyers: The buyers have moderate bargaining power as there are few alternatives available for treatment and prevention.

Bargaining power of suppliers: The suppliers of raw materials and key components have moderate bargaining power due to established supply relationships

Threat of new substitutes: There is no effective substitute currently available for cholera vaccines. Alternative oral rehydration solutions have limited effectiveness.

Competitive rivalry: The market is dominated by few global players. Price competition is moderate due to differentiated products and regulated markets.

Geographical Regions

Sub-Saharan Africa accounts for over 50% of the Zambia cholera vaccines market share in terms of value. Countries like DR Congo, Mozambique, Nigeria, and Ethiopia contribute significantly to the outbreaks reported from the region annually, driving the need for vaccination programs.

Asia Pacific region is poised to witness the fastest growth during the forecast period in the Zambia cholera vaccines market. Increasing investments towards immunization and better sanitation in densely populated countries like India and Bangladesh are supporting the market expansion.

Get more insights on Zambia Cholera Vaccines Market

About Author:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )